Home
/
ZIMMER BIOMET HOLDINGS, INC.
/
Financials
/
Quarterly
ZIMMER BIOMET HOLDINGS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ZIMMER BIOMET HOLDINGS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.00B
Nov 5, 2025
Q2
2025
Jun 30, 2025
$2.08B
Aug 7, 2025
Q1
2025
Mar 31, 2025
$1.91B
May 5, 2025
Q3
2025
Sep 30, 2024
$1.82B
Nov 5, 2025
Q2
2025
Jun 30, 2024
$1.94B
Aug 7, 2025
Q1
2025
Mar 31, 2024
$1.89B
May 5, 2025
Q3
2024
Sep 30, 2023
$1.75B
Oct 30, 2024
Q2
2024
Jun 30, 2023
$1.87B
Aug 7, 2024
Q1
2024
Mar 31, 2023
$1.83B
May 2, 2024
Q3
2023
Sep 30, 2022
$1.67B
Nov 7, 2023
Q2
2023
Jun 30, 2022
$1.78B
Aug 1, 2023
Q1
2023
Mar 31, 2022
$1.66B
May 2, 2023
Q3
2022
Sep 30, 2021
$1.69B
Nov 2, 2022
Q2
2022
Jun 30, 2021
$1.76B
Aug 2, 2022
Q1
2022
Mar 31, 2021
$1.60B
May 5, 2022
Q3
2021
Sep 30, 2020
$1.93B
Nov 4, 2021
Q2
2021
Jun 30, 2020
$1.23B
Aug 3, 2021
Q1
2021
Mar 31, 2020
$1.78B
May 4, 2021
Q3
2020
Sep 30, 2019
$1.89B
Nov 6, 2020
Q2
2020
Jun 30, 2019
$1.99B
Aug 5, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2011
Mar 31, 2011
$1.12B
May 5, 2011
Q3
2010
Sep 30, 2010
$965.00M
Nov 3, 2010
Q2
2010
Jun 30, 2010
$1.06B
Aug 5, 2010
Q1
2010
Mar 31, 2010
$1.06B
May 5, 2010
Q3
2009
Sep 30, 2009
$975.60M
Nov 4, 2009
Q2
2009
Jun 30, 2009
$1.02B
Aug 17, 2009
Q1
2010
Mar 31, 2009
$992.60M
May 5, 2010
Q3
2009
Sep 30, 2008
$952.20M
Nov 4, 2009
Q2
2009
Jun 30, 2008
$1.08B
Aug 17, 2009
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$230.90M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$152.80M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$182.00M
May 5, 2025
Q3
2025
Sep 30, 2024
$249.10M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$242.80M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$172.40M
May 5, 2025
Q3
2024
Sep 30, 2023
$162.70M
Oct 30, 2024
Q2
2024
Jun 30, 2023
$209.60M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$232.50M
May 2, 2024
Q3
2023
Sep 30, 2022
$194.00M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$153.70M
Aug 1, 2023
Q1
2023
Mar 31, 2022
$14.20M
May 2, 2023
Q3
2022
Sep 30, 2021
$145.60M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$141.90M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$198.10M
May 5, 2022
Q3
2021
Sep 30, 2020
$242.50M
Nov 4, 2021
Q2
2021
Jun 30, 2020
($206.60M)
Aug 3, 2021
Q1
2021
Mar 31, 2020
($508.50M)
May 4, 2021
Q3
2020
Sep 30, 2019
$431.10M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$133.70M
Aug 5, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$351.30M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$300.00M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$292.30M
May 5, 2025
Q3
2025
Sep 30, 2024
$279.50M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$351.30M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$265.90M
May 5, 2025
Q3
2024
Sep 30, 2023
$266.60M
Oct 30, 2024
Q2
2024
Jun 30, 2023
$329.60M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$327.30M
May 2, 2024
Q3
2023
Sep 30, 2022
$245.30M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$280.90M
Aug 1, 2023
Q1
2023
Mar 31, 2022
$198.40M
May 2, 2023
Q3
2022
Sep 30, 2021
$243.00M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$224.80M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$258.70M
May 5, 2022
Q3
2021
Sep 30, 2020
$299.20M
Nov 4, 2021
Q2
2021
Jun 30, 2020
($171.70M)
Aug 3, 2021
Q1
2021
Mar 31, 2020
($456.00M)
May 4, 2021
Q3
2020
Sep 30, 2019
$245.80M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$204.70M
Aug 5, 2020